Cargando…

1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ

BACKGROUND: Transplant candidates and recipients are at increased risk of infectious complications of vaccine-preventable diseases due to their longstanding immunosuppressive regimens. We assessed the rates of vaccination in our liver transplant patients at University Hospital (UH) in Newark, NJ. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Varughese, Tilly, Song, Michael, Sackey, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644647/
http://dx.doi.org/10.1093/ofid/ofab466.1571
_version_ 1784610134382608384
author Varughese, Tilly
Song, Michael
Sackey, Joachim
author_facet Varughese, Tilly
Song, Michael
Sackey, Joachim
author_sort Varughese, Tilly
collection PubMed
description BACKGROUND: Transplant candidates and recipients are at increased risk of infectious complications of vaccine-preventable diseases due to their longstanding immunosuppressive regimens. We assessed the rates of vaccination in our liver transplant patients at University Hospital (UH) in Newark, NJ. METHODS: Retrospective chart-review including patients > 18 years old who underwent liver transplantation at UH for a 3-year period from 01/01/2017 to 07/20/2020. Data collected included demographics, clinical outcomes, eligibility and receipt of vaccinations before and after transplantation, protection titers after administration of hepatitis vaccinations and presence of an ID outpatient consultation. We looked at the following receipt of vaccinations: Prevnar-13, Pneumovax-23, Influenza, TDaP, Shingrix, Varivax, Havrix and Engerix/Heplisav. Characteristics of study participants was analyzed using descriptive statistics and Chi-Square/Fisher’s Exact tests were used to test associations. RESULTS: 119 unique medical charts were reviewed and no patients were excluded. Of those patients who were eligible to receive Hepatitis A vaccination, only 44.8% were documented to receive vaccination and of those eligible to receive Hepatitis B vaccination, only 47.8% received it. Influenza vaccination pre-transplantation was 46% and 66.1% in post-transplant recipients. For the other vaccinations, during the pre-transplant period, 17.6 % of patients received Prevnar-13, 36.1% Pneumovax-23 and 20.2% TDaP and 26.1% received Shingrix. Patients who had ID consultation were significantly more likely to receive appropriate Hepatitis A and Hepatitis B vaccinations (p values 0.026 and 0.005). [Image: see text] [Image: see text] [Image: see text] CONCLUSION: We are not meeting national vaccination standards set by the American Society of Transplantation (AST) for optimal vaccination in this population. Our study can inform of possible solutions to increase vaccination rates in this population such as the simple addition of a smartphrase within EMR notes to remind providers to order appropriate vaccinations and eventually, a more long term solution of creation of a dedicated vaccination clinic and/or routine ID pre-transplant evaluations for all transplant candidates. [Image: see text] DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644647
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86446472021-12-06 1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ Varughese, Tilly Song, Michael Sackey, Joachim Open Forum Infect Dis Poster Abstracts BACKGROUND: Transplant candidates and recipients are at increased risk of infectious complications of vaccine-preventable diseases due to their longstanding immunosuppressive regimens. We assessed the rates of vaccination in our liver transplant patients at University Hospital (UH) in Newark, NJ. METHODS: Retrospective chart-review including patients > 18 years old who underwent liver transplantation at UH for a 3-year period from 01/01/2017 to 07/20/2020. Data collected included demographics, clinical outcomes, eligibility and receipt of vaccinations before and after transplantation, protection titers after administration of hepatitis vaccinations and presence of an ID outpatient consultation. We looked at the following receipt of vaccinations: Prevnar-13, Pneumovax-23, Influenza, TDaP, Shingrix, Varivax, Havrix and Engerix/Heplisav. Characteristics of study participants was analyzed using descriptive statistics and Chi-Square/Fisher’s Exact tests were used to test associations. RESULTS: 119 unique medical charts were reviewed and no patients were excluded. Of those patients who were eligible to receive Hepatitis A vaccination, only 44.8% were documented to receive vaccination and of those eligible to receive Hepatitis B vaccination, only 47.8% received it. Influenza vaccination pre-transplantation was 46% and 66.1% in post-transplant recipients. For the other vaccinations, during the pre-transplant period, 17.6 % of patients received Prevnar-13, 36.1% Pneumovax-23 and 20.2% TDaP and 26.1% received Shingrix. Patients who had ID consultation were significantly more likely to receive appropriate Hepatitis A and Hepatitis B vaccinations (p values 0.026 and 0.005). [Image: see text] [Image: see text] [Image: see text] CONCLUSION: We are not meeting national vaccination standards set by the American Society of Transplantation (AST) for optimal vaccination in this population. Our study can inform of possible solutions to increase vaccination rates in this population such as the simple addition of a smartphrase within EMR notes to remind providers to order appropriate vaccinations and eventually, a more long term solution of creation of a dedicated vaccination clinic and/or routine ID pre-transplant evaluations for all transplant candidates. [Image: see text] DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644647/ http://dx.doi.org/10.1093/ofid/ofab466.1571 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Varughese, Tilly
Song, Michael
Sackey, Joachim
1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ
title 1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ
title_full 1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ
title_fullStr 1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ
title_full_unstemmed 1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ
title_short 1379. Vaccination Rates among Liver Transplant Recipients at a Tertiary Care Hospital in Newark, NJ
title_sort 1379. vaccination rates among liver transplant recipients at a tertiary care hospital in newark, nj
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644647/
http://dx.doi.org/10.1093/ofid/ofab466.1571
work_keys_str_mv AT varughesetilly 1379vaccinationratesamonglivertransplantrecipientsatatertiarycarehospitalinnewarknj
AT songmichael 1379vaccinationratesamonglivertransplantrecipientsatatertiarycarehospitalinnewarknj
AT sackeyjoachim 1379vaccinationratesamonglivertransplantrecipientsatatertiarycarehospitalinnewarknj